Riskpilot← Back to searchSign inGet full accessSolvang Genetics ApS
APSActiveCVR 42924911Alleshavevej 64Raising of swine and pigs · NACE 0146Est. 202110 employees
Revenue 2024
DKK 6M
-24% vs 2023
EBITDA margin
30.3%
-53% vs 2023
Equity ratio
8.9%
Financial strength
Net profit 2024
DKK 358K
-85% vs 2023
| Revenue | DKK 6M | -24% |
| EBITDA | DKK 1,8M | -53% |
| Net profit | DKK 358K | -85% |
| Total assets | DKK 21,1M | +4% |
| Equity | DKK 1,9M | +23% |
| Employees | 10 | — |
Legal name
Solvang Genetics ApS
CVR number
42924911
Legal form
Anpartsselskab
NACE code
0146 · Raising of swine and pigs
Founded
22. december 2021
Share capital
DKK 40.000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at drive virksomhed med opformering af svin, svineavl og dermed beslægtet virksomhed og efter direktionens bestemmelse anden virksomhed, som står i naturlig forbindelse hermed.
Address
Alleshavevej 64
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 765 | 7.947 | 6.019 |
| Staff expenses | -1.101 | -4.089 | -4.156 |
| EBITDA | -336 | 3.858 | 1.826 |
| Depreciation & amort. | -56 | -56 | -58 |
| EBIT | -392 | 3.802 | 1.768 |
| Net financials | -614 | -982 | -1.158 |
| Profit before tax | -1.006 | 2.821 | 610 |
| Tax | -179 | 503 | 252 |
| Net profit | -827 | 2.318 | 358 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 20.575 | 20.392 | 21.124 |
| Equity | -787 | 1.531 | 1.889 |
| Long-term debt | 17.800 | 15.495 | 11.147 |
| Short-term debt | 3.562 | 3.036 | 7.506 |
| Total debt | 21.362 | 18.531 | 18.652 |
EBITDA margin
30.3%
This company
15.8%
Market median
+92% vs market
20222024
Equity ratio
8.9%
This company
38.2%
Market median
-77% vs market
20222024
Return on equity
19.0%
This company
18.4%
Market median
+3% vs market
20222024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20222024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20222024
Debt / equity
10.18×
This company
0.62×
Market median
-1542% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2021-12-22 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
UR Founder | Founder | 2021 | — | — |
NH Management | Management | 2025 | — | — |
MW Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
MH Management | Management | 2026 | — | — |
RJ Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Danish Genetics Holding ApS | Company | 100.0% | 100.0% | 2025 |
Ulrik Lundgaard Holding ApS | Company | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Danish Genetics Holding ApS
Solvang Genetics ApS Board members of Solvang Genetics ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrik Rønnenkamp Lundgaard | Founder | 0 companies |
| Niels Henrik Reventlow | Management | 0 companies |
| Mikael Wædeled Sigvardsen | Chief Executive Officer | 0 companies |
| Mads Hans Kring | Management | 0 companies |
| Rafael Jacobus Henri Gerard Beeren | Chief Executive Officer | 0 companies |